The CML-CP is causally associated with the Breakpoint Cluster Region (BCR) and Abelson (ABL) gene fusion (BCR-ABL)3, 4. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.